Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60M
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
34.2M
-
Shares change
-
-3.27M
-
Total reported value, excl. options
-
$131M
-
Value change
-
-$14.8M
-
Put/Call ratio
-
0.07
-
Number of buys
-
68
-
Number of sells
-
-53
-
Price
-
$3.83
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q2 2025
154 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q2 2025.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.2M shares
of 60M outstanding shares and own 57.03% of the company stock.
Largest 10 shareholders include Knoll Capital Management, LLC (5.48M shares), PERCEPTIVE ADVISORS LLC (4.05M shares), BlackRock, Inc. (3.85M shares), VANGUARD GROUP INC (3.5M shares), ARDSLEY ADVISORY PARTNERS LP (2.05M shares), AQR CAPITAL MANAGEMENT LLC (1.47M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1.33M shares), GEODE CAPITAL MANAGEMENT, LLC (1.15M shares), 683 Capital Management, LLC (1.08M shares), and STATE STREET CORP (1.06M shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.